26/09/2017
Dynacure joins ongoing Natural History Study in Centronuclear Myopathies with the Institute of Myology
Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathy (CNM), a debilitating rare disease affecting children and young adults. [...]
